KR100256664B1 - 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna - Google Patents

단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna Download PDF

Info

Publication number
KR100256664B1
KR100256664B1 KR1019940031010A KR19940031010A KR100256664B1 KR 100256664 B1 KR100256664 B1 KR 100256664B1 KR 1019940031010 A KR1019940031010 A KR 1019940031010A KR 19940031010 A KR19940031010 A KR 19940031010A KR 100256664 B1 KR100256664 B1 KR 100256664B1
Authority
KR
South Korea
Prior art keywords
protein
dna
polypeptide
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940031010A
Other languages
English (en)
Korean (ko)
Other versions
KR950014135A (ko
Inventor
다지마히사오
기타가와고이치로
오노히로유키
Original Assignee
오노 야꾸힝 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오노 야꾸힝 고교 가부시키가이샤 filed Critical 오노 야꾸힝 고교 가부시키가이샤
Publication of KR950014135A publication Critical patent/KR950014135A/ko
Application granted granted Critical
Publication of KR100256664B1 publication Critical patent/KR100256664B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940031010A 1993-11-24 1994-11-24 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna Expired - Fee Related KR100256664B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP93-315806 1993-11-24
JP31580693 1993-11-24

Publications (2)

Publication Number Publication Date
KR950014135A KR950014135A (ko) 1995-06-15
KR100256664B1 true KR100256664B1 (ko) 2000-05-15

Family

ID=18069786

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940031010A Expired - Fee Related KR100256664B1 (ko) 1993-11-24 1994-11-24 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna

Country Status (11)

Country Link
US (5) US5506205A (enExample)
EP (1) EP0659883B1 (enExample)
KR (1) KR100256664B1 (enExample)
CN (1) CN1057096C (enExample)
AT (1) ATE237683T1 (enExample)
CA (1) CA2136565C (enExample)
DE (1) DE69432511T2 (enExample)
DK (1) DK0659883T3 (enExample)
ES (1) ES2196016T3 (enExample)
PT (1) PT659883E (enExample)
TW (1) TW311913B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506205A (en) 1993-11-24 1996-04-09 Ono Pharmaceutical Co., Ltd. Polypeptide of protein p140 and DNAs encoding it
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
GB0208089D0 (en) 2002-04-09 2002-05-22 Oxford Glycosciences Uk Ltd Protein
EP2046313A4 (en) * 2006-07-10 2012-01-25 Glucox Biotech Ab USE OF NAPHTHOCHINONES IN THE TREATMENT AND CONTROL OF DIABETES, INSULIN RESISTANCE AND HYPERGLYCEMIA
EP2517725A1 (en) * 2007-05-01 2012-10-31 Board Of Regents, The University Of Texas Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
CN105085630A (zh) * 2015-08-31 2015-11-25 苏州普罗达生物科技有限公司 mTOR抑制多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260200A (en) * 1991-01-18 1993-11-09 Joslin Diabetes Center, Inc. Isolated DNA encoding an insulin receptor substrate
US5811396A (en) * 1991-03-14 1998-09-22 The United States Of America As Represented By The Department Of Health And Human Services TRK tyrosine kinase receptor is the physiological receptor for nerve growth factor
US5506205A (en) * 1993-11-24 1996-04-09 Ono Pharmaceutical Co., Ltd. Polypeptide of protein p140 and DNAs encoding it

Also Published As

Publication number Publication date
US5506205A (en) 1996-04-09
DK0659883T3 (da) 2003-08-04
ATE237683T1 (de) 2003-05-15
KR950014135A (ko) 1995-06-15
CN1112127A (zh) 1995-11-22
DE69432511T2 (de) 2004-04-29
PT659883E (pt) 2003-07-31
CA2136565C (en) 1999-11-09
DE69432511D1 (de) 2003-05-22
US5804411A (en) 1998-09-08
EP0659883B1 (en) 2003-04-16
US6432913B1 (en) 2002-08-13
CA2136565A1 (en) 1995-05-25
EP0659883A2 (en) 1995-06-28
ES2196016T3 (es) 2003-12-16
US20030170865A1 (en) 2003-09-11
US6303320B1 (en) 2001-10-16
TW311913B (enExample) 1997-08-01
EP0659883A3 (en) 1997-06-25
CN1057096C (zh) 2000-10-04

Similar Documents

Publication Publication Date Title
KR100391227B1 (ko) 인체의 프로그램화 된 세포사멸과 관련있는 펩티드 및 이를 암호하는 디엔에이(dna)
KR100631766B1 (ko) 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및그들의 용도
Plager et al. A novel and highly divergent homolog of human eosinophil granule major basic protein
WO1999010364A1 (en) Follistatin-3
EP3530667B1 (en) Peptide having anti-obesity and anti-diabetes efficacy and use thereof
JPH09509570A (ja) Ｍｔｓ−１遺伝子により転移性癌の診断
US6638741B2 (en) Differentiation-suppressive polypeptide serrate-2
US20140088024A1 (en) Vesiculins
KR100256664B1 (ko) 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna
US5948643A (en) Modulators of BRCA1 activity
JPH04500603A (ja) クローン化腎炎抗原
US5955579A (en) Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13
US20050069557A1 (en) Vertebrate globin
EP0628631A1 (en) A phosphatidylethanolamine binding protein derived from a human glioblastoma cell line and DNA encoding it
US7749758B2 (en) Human and mammalian stem cell-derived neuron survival factors
KR20020077028A (ko) 샤페론 기능을 수행하는 신규 스트레스 단백질
EP0620278A1 (en) Human transaldolase and DNA encoding therefor
CN1313297A (zh) 具有抑制癌细胞生长功能的新的人蛋白及其编码序列
EP0624648A1 (en) Polypeptide derived form a human glioblastoma cell line and DNA's encoding it
EP0619371A1 (en) Polypeptide derived from a glioblastoma cell line, its use and DNAs encoding it
WO2009030087A1 (fr) Fonctions et utilisations de la protéine 4 se liant à la phosphatidyléthanolamine
JPH07215890A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、ベクター、宿主細胞、そのポリペプチドの抗体、そのポリペプチドまたは抗体を含有する薬学的組成物、糖尿病の予防・治療方法および予防・治療剤、並びにその予防・治療剤のスクリーニング方法
WO2003057883A1 (fr) Facteur 5 de croissance derive de l'hepatome humain, sa sequence codante, procede pour le produire et ses utilisations
WO2001027285A1 (en) A novel polypeptide, a human dpb methyltransferase 41 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20040204

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20050225

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20050225